Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TELMAR: Telmisartan vs Metoprolol in Hypertension with LVH
NCT02242812Phase 4Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Primary endpoint: Percentage change in left ventricular mass index relative to height at 6.5 months. Started Sep 2003; status: terminated.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02242812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242812.